Literature DB >> 17475465

Is metabolic syndrome X a disorder of the brain with the initiation of low-grade systemic inflammatory events during the perinatal period?

Undurti N Das1.   

Abstract

An imbalance between pro- and anti-inflammatory molecules occurs in metabolic syndrome X. High-energy diet, saturated fats and trans-fats during perinatal period could suppress Delta(6) and Delta(5) desaturases both in the maternal and fetal tissues, resulting in a decrease in the concentrations of long-chain polyunsaturated fatty acids (LCPUFAs): arachidonic acid (AA), eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) that have a negative feedback control on inflammation. EPA, DHA and AA augment endothelial nitric oxide synthesis, potentiate insulin action both in the peripheral tissues and brain and alter leptin production. LCPUFAs are essential for brain growth and development and synaptogenesis and modulate the action of several neurotransmitters and hypothalamic peptides. This suggests that metabolic syndrome X could be a disorder of the brain due to suboptimal LCPUFAs during perinatal period that triggers low-grade systemic inflammation, implying that perinatal strategies are needed to prevent its development.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475465     DOI: 10.1016/j.jnutbio.2007.01.002

Source DB:  PubMed          Journal:  J Nutr Biochem        ISSN: 0955-2863            Impact factor:   6.048


  17 in total

1.  Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet.

Authors:  Fatima Kasbi-Chadli; Véronique Ferchaud-Roucher; Michel Krempf; Khadija Ouguerram
Journal:  Eur J Nutr       Date:  2015-03-19       Impact factor: 5.614

Review 2.  Linking Alzheimer's disease and type 2 diabetes mellitus via aberrant insulin signaling and inflammation.

Authors:  Mohammad A Kamal; Shubha Priyamvada; Arivarasu N Anbazhagan; Nasimudeen R Jabir; Shams Tabrez; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2014-03       Impact factor: 4.388

3.  Hypothesis: Intensive insulin therapy-induced mortality is due to excessive serotonin autoinhibition and autonomic dysregulation.

Authors:  Undurti N Das
Journal:  World J Diabetes       Date:  2010-09-15

4.  Inhibition of Butyrylcholinesterase with Fluorobenzylcymserine, An Experimental Alzheimer's Drug Candidate: Validation of Enzoinformatics Results by Classical and Innovative Enzyme Kinetic Analyses.

Authors:  Mohammad A Kamal; Shazi Shakil; Muhammad S Nawaz; Qian-Sheng Yu; David Tweedie; Y Tan; Xianqin Qu; Nigel H Greig
Journal:  CNS Neurol Disord Drug Targets       Date:  2017       Impact factor: 4.388

5.  Vagal nerve stimulation in prevention and management of coronary heart disease.

Authors:  Undurti N Das
Journal:  World J Cardiol       Date:  2011-04-26

6.  Joint association of physical activity/screen time and diet on CVD risk factors in 10-year-old children.

Authors:  Clemens Drenowatz; Joseph J Carlson; Karin A Pfeiffer; Joey C Eisenmann
Journal:  Front Med       Date:  2012-12-07       Impact factor: 4.592

7.  Why and How Meet n-3 PUFA Dietary Recommendations?

Authors:  Olivier Molendi-Coste; Vanessa Legry; Isabelle A Leclercq
Journal:  Gastroenterol Res Pract       Date:  2010-12-08       Impact factor: 2.260

8.  Can essential fatty acids reduce the burden of disease(s)?

Authors:  Undurti N Das
Journal:  Lipids Health Dis       Date:  2008-03-18       Impact factor: 3.876

9.  Allergic fetal priming leads to developmental, behavioral and neurobiological changes in mice.

Authors:  J J Schwartzer; M Careaga; C Chang; C E Onore; P Ashwood
Journal:  Transl Psychiatry       Date:  2015-04-07       Impact factor: 6.222

10.  Gene expression profile in obesity and type 2 diabetes mellitus.

Authors:  Undurti N Das; Allam A Rao
Journal:  Lipids Health Dis       Date:  2007-12-14       Impact factor: 3.876

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.